UK Myocardial Infarction Market Size, Industry Trends, Share and Forecast 2020-2026
UK myocardial
infarction (MI) market is estimated to grow considerably at a CAGR of around
7.2% during the forecast period. UK has one of the finest healthcare systems in
the EU region which enables it to provide quality healthcare to the individual
citizens. UK has the highest number of CVD, CHD, MI, stroke, heart failure,
atrial fibrillation, and other heart patients. According to the British Heart
Foundation, more than one- a fourth of the fatalities in UK are due to CVD,
which is responsible for around 1.6 million fatalities each year. The critical
factors that are leading to CVD, CHD, MI, stroke, and other heart diseases
include work-related stress, depression, excessive consumption of alcohol,
excessive smoking, hypertension, diabetes, obesity, and poor diet which
includes cholesterol.
A full Report of UK Myocardial Infarction
Market at https://www.omrglobal.com/industry-reports/uk-myocardial-infarction-market
The market is
segmented into type, device, diagnosis, treatment, and end-user. Based on type,
the market is segmented into ST-elevation myocardial infarction (STEMI) heart
attacks, non-ST elevation myocardial infarction (NSTEMI) heart attacks, and
silent heart attacks. Based on the device, the market is segmented into left
ventricular assist device, pacemaker, implantable cardioverter defibrillator,
and others (aspiration-based catheters). Based on the diagnosis, the market is
segmented into an electrocardiography (ECG), chest X-Ray, Computed Tomography
(CT Scan), echocardiography, and others (blood test). Based on treatment, the
market is segmented into medication and surgery. Based on end-user, the market
is segmented into hospitals & clinics, Ambulatory Surgical Centers (ASCs),
and research institutes.
Request a Free Sample of Report on UK Myocardial Infarction Market @ https://www.omrglobal.com/request-sample/uk-myocardial-infarction-market
UK Myocardial
Infarction Market Segmentation
By Type
·
Non-ST-elevation myocardial infarction (NSTEMI)
·
ST-elevation myocardial infarction (STEMI)
·
Silent Heart Attacks
By Device
·
Left Ventricular Assist Device (LVAD)
·
Pacemaker
·
Catheters
·
Implantable Cardioverter-Defibrillator (ICD)
·
Others (Stent Graft)
By Diagnosis
·
Electrocardiography (ECG)
·
Chest X-Ray
·
Computed Tomography (CT Scan)
·
Echocardiography
·
Others (Blood Test)
By Treatment
·
Medication
·
Surgery
By End-User
·
Hospital & Clinics
·
Ambulatory Surgical Centers
·
Research Institutes
Regional
Analysis
·
China
·
Japan
·
India
·
Rest of Asia-Pacific
Company
Profiles
·
Abbott Laboratories Inc.
·
AstraZeneca PLC
·
Bayer AG
·
Boston Scientific Corp.
·
Bristol-Myers Squibb Co.
·
CSL Ltd.
·
Eli Lilly and Co.
·
GlaxoSmithKline Plc
·
Johnson & Johnson Services, Inc.
·
Medtronic PLC
·
Merck KGaA
·
Mesoblast Ltd.
·
Mylan N.V.
·
Novartis AG
·
Pfizer Inc.
·
Siemens AG
For
More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-myocardial-infarction-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91
780-304-0404
Comments
Post a Comment